33 followers
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases. https://t.co/HyCOGGUIim
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases. https://t.co/HyCOGGUIim
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated ... https://t.co/xvzfqksFut
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases. https://t.co/p3D0MYa6oZ
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases. https://t.co/OF29pgHAuP https://t.co/Ct5SFFbvcw